Equities

Micropos Medical AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MPOS:AKT

Micropos Medical AB (publ)

Actions
  • Price (SEK)1.06
  • Today's Change-0.01 / -0.93%
  • Shares traded135.89k
  • 1 Year change-54.71%
  • Beta0.3357
Data delayed at least 15 minutes, as of Feb 09 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Micropos Medical AB (publ) is a Sweden-based company engaged in the development of medical devices for high precision four dimensional (4D) radiotherapy. The Company’s product is RayPilot, an electromagnetic positioning system that enables real time information of the position of the prostate. The system works as an add-on to existing linear accelerators and enables control of a region of interest (ROI) position throughout every radiotherapy session. It consists of RayPilot receiving system, RayPilot transmitter that is placed in the ROI, and RayPilot software. The Company markets its products through sales offices in the Nordic countries, a network of distributors in Europe, the United States and Asia, and through Business to Business (B2B) partnerships with T ex Elekta and Varian & Siemens.

  • Revenue in SEK (TTM)8.08m
  • Net income in SEK-21.73m
  • Incorporated2003
  • Employees9.00
  • Location
    Micropos Medical AB (publ)Adolf Edelsvards Gata 11GOETEBORG 414 51SwedenSWE
  • Phone+46 317728100
  • Fax+46 317728091
  • Websitehttps://micropos.se/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Arcoma AB132.94m4.35m104.45m31.0022.771.429.020.78570.32050.32059.875.131.452.9213.714,288,452.004.752.166.663.7540.4537.953.271.402.04--0.000.00-3.813.24336.0011.08-9.43--
Immunovia AB (publ)785.00k-125.52m122.56m9.00------156.13-0.3569-0.35690.0024-0.0210.0156--0.26487,222.22-249.16-48.08-827.53-52.27-7,231.59-6,932.30-15,989.68-17,625.510.6282-3.001.68---40.8921.2075.26------
BibbInstruments AB149.00k-13.30m131.18m4.00--3.07--880.41-0.3802-0.38020.00411.050.00382.062.7137,250.00-33.98-36.85-35.53-40.0630.8759.14-8,922.82-22,555.646.67--0.00-------15.85---1.52--
Scandinavian Real Heart AB0.00-38.87m138.46m12.00--0.8296-----16.17-16.170.0016.690.00----0.00-44.53-27.49-52.77-30.65-------12,518.77----0.0678------49.47--6.59--
Bioretec Oy-1.06tn-1.06tn144.98m57.00---------------------------57.56---77.31--70.90---128.20--------16.3221.07-21.78------
Ortivus AB75.91m-24.74m150.86m34.00------1.99-0.5583-0.55831.71-0.50621.186.7716.222,372,281.00-38.46-4.62-147.30-8.6534.7941.27-32.59-3.550.4719-4.011.72---4.369.60-36.49--65.37--
Scandinavian Medical Solutions A/S349.21m36.99k152.71m28.005,848.491.2912.260.43730.00070.00078.882.991.291.9411.19--0.01376.590.024611.6823.1224.880.01064.680.35241.140.4345--8.2842.38-99.67-64.34----
Bactiquant A/S11.75m-18.61m163.09m----11.22--13.88-0.4696-0.46960.29660.27230.46562.6915.14---73.73-55.41-85.85-64.53-31.80-10.94-158.37-121.813.26-9.700.1926---41.68-14.27-4.72------
iZafe Group AB5.90m-17.73m165.90m10.00--10.08--28.11-0.0614-0.06140.01940.04520.17573.448.15843,000.00-52.78-57.76-73.42-72.44-106.29-287.24-300.41-630.900.9122-17.450.0198--336.55-11.1036.26---24.50--
Micropos Medical AB (publ)8.08m-21.73m176.49m9.00------21.85-0.1398-0.13980.0514-------------83.62---110.96120.0394.59-268.99-558.00---99.12----112.4917.010.7589---16.83--
BrainCool AB (publ)43.62m-36.85m181.45m20.00--1.03--4.16-0.1408-0.14080.16660.44790.28411.152.922,180,769.00-24.00-38.93-26.22-53.1029.8648.00-84.48-233.832.29-33.110.00--72.0556.5028.13--4.34--
Boule Diagnostics AB512.66m-80.68m200.38m186.00--1.19--0.3909-2.09-2.0913.334.341.034.614.042,268,420.00-16.14-9.09-28.43-13.2842.8843.62-15.74-11.160.775323.700.5491---2.252.28-1,287.41--7.84--
Subgen AI AB0.00-64.18m201.55m15.00---------544.10-544.100.00-25.110.00----0.00-188.83---403.12-------------4.46-----100.00--16.86------
SciBase Holding AB (publ)36.58m-90.39m215.38m34.00--3.86--5.89-0.2487-0.24870.09780.06740.66481.293.231,143,250.00-164.26-75.65-244.76-101.0166.0465.08-247.08-256.982.07-11.750.00--27.7926.21-9.97---20.49--
Integrum AB97.00m-29.85m229.57m37.00--1.21--2.37-1.37-1.374.507.260.52530.8283.402,487,052.00-16.17-3.58-17.87-4.0875.6183.88-30.78-6.471.88--0.025---12.5027.78-864.22--103.14--
Prolight Diagnostics AB (publ)0.00-35.57m232.22m21.00--1.28-----4.03-4.030.0015.080.00----0.00-19.97---24.07--------------0.00------80.11---1.65--
Data as of Feb 09 2026. Currency figures normalised to Micropos Medical AB (publ)'s reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.